Oligonucleotides & Peptides World Asia Congress 2026 (Biopharma Asia)

The Oligonucleotides & Peptides World Asia Congress 2026 is the region’s leading platform dedicated to advancing oligonucleotide and peptide-based therapeutics across the value chain , from early-stage R&D and clinical trials to large-scale manufacturing.

As Asia emerges as a key hub for next-generation therapeutics, this Congress brings together biopharma and big pharma leaders and regulatory experts to exchange insights, explore innovation, and strengthen regional collaboration. Through a carefully curated program featuring case studies from across APAC, the Congress aims to accelerate development pipelines and manufacturing excellence in oligonucleotide and peptide therapies.

Spanning eight focused sessions, the Oligonucleotides & Peptides World Asia Congress 2026 will explore the latest in ASOs, siRNA, and peptide therapeutics; innovative delivery and formulation technologies; and advances in clinical trials and translational research across APAC. The program will also address scalable manufacturing, evolving regulatory frameworks, emerging digital and platform innovations, and best practices in quality and analytical strategies — offering a comprehensive view of Asia’s growing oligonucleotide and peptide ecosystem from R&D to large-scale production.

Join us at Oligonucleotides & Peptides World Asia Congress 2026 to connect with leading experts, gain actionable insights, and be part of the movement shaping Asia’s oligonucleotide and peptide revolution.

Group Booking Discounts:

Buy 3 get 10% off, Buy 5 get 20% off, Buy 6 or more get 25% off
*Contact your Sales/Marketing Representative for discount availablity